Intravenous apoA-I/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans.

The extent to which plasma HDL concentration regulates reverse cholesterol transport (RCT) is not known. The principal acceptors of unesterified cholesterol (UC) from cultured cells are small pre-beta-HDL, which we have shown increase in plasma during intravenous infusion of apolipoprotein A-I/phosphatidylcholine (apoA-I/PC) discs in humans. We have now examined the effects on tissue fluid HDL and RCT. ApoA-I/PC or proapoA-I/PC discs were infused into 16 healthy males. Eleven had been given intravenous radiocholesterol to label tissue pools; in 12 prenodal leg lymph was collected throughout; and in 8 all feces were collected. The rise in small pre-beta-HDL in plasma was associated with increases in 1) pre-beta-HDL concentration in lymph (all subjects), 2) the size of other lymph HDL (four of four subjects), 3) the cholesterol content of lymph lipoproteins relative to plasma lipoproteins (P < 0.01, n = 4), 4) cholesterol-specific radioactivity in lymph (five of nine subjects), 5) plasma lathosterol (P < 0.004, n = 4), 6) plasma cholesterol esterification rate (P < 0.001, n = 4), and 7) fecal bile acid excretion (P < 0.001, n = 8). These results support the hypothesis that small pre-beta-HDL generated in plasma readily cross endothelium into tissue fluid, and thereby promote efflux of UC from peripheral cells. After delivery to the liver, peripheral cholesterol appears to be utilized more for bile acid synthesis than for biliary cholesterol secretion in humans.

[1]  W. Olszewski,et al.  Concentrations of Electrophoretic and Size Subclasses of Apolipoprotein A-I–Containing Particles in Human Peripheral Lymph , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[2]  W. Olszewski,et al.  Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency. , 2000, Journal of lipid research.

[3]  E. Brinton,et al.  Very small apolipoprotein A-I-containing particles from human plasma: isolation and quantification by high-performance size-exclusion chromatography. , 2000, Clinical chemistry.

[4]  M. Eriksson,et al.  Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans. , 1999, Circulation.

[5]  M. Krieger.  Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. , 1999, Annual review of biochemistry.

[6]  O. Stein,et al.  High levels of human apolipoprotein A-I and high density lipoproteins in transgenic mice do not enhance efflux of cholesterol from a depot of injected lipoproteins. Relevance to regression of atherosclerosis? , 1999, Atherosclerosis.

[7]  P. Lerch,et al.  Acute effects of intravenous infusion of ApoA1/phosphatidylcholine discs on plasma lipoproteins in humans. , 1999, Arteriosclerosis, Thrombosis and Vascular Biology.

[8]  J. Dietschy,et al.  Centripetal cholesterol flux to the liver is dictated by events in the peripheral organs and not by the plasma high density lipoprotein or apolipoprotein A-I concentration. , 1998, Journal of lipid research.

[9]  H. Hobbs,et al.  Kinetic characteristics and regulation of HDL cholesteryl ester and apolipoprotein transport in the apoA-I 2 / 2 mouse , 1998 .

[10]  J. Breslow,et al.  Delayed loss of cholesterol from a localized lipoprotein depot in apolipoprotein A-I-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Lerch,et al.  Production and Characterization ofa Reconstituted High Density Lipoprotein for Therapeutic Applications , 1996, Vox sanguinis.

[12]  C. Fielding,et al.  Molecular physiology of reverse cholesterol transport. , 1995, Journal of lipid research.

[13]  E. Bravo,et al.  The role of lipoprotein cholesterol in biliary steroid secretion. Studies with in vivo experimental models. , 1995, Progress in lipid research.

[14]  C. Fielding,et al.  Quantitation of pre beta-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid. , 1993, Biochemistry.

[15]  A. Jonas,et al.  The number of amphipathic alpha-helical segments of apolipoproteins A-I, E, and A-IV determines the size and functional properties of their reconstituted lipoprotein particles. , 1993, The Journal of biological chemistry.

[16]  D. Russell,et al.  Bile acid biosynthesis. , 1992, Biochemistry.

[17]  F. Czubayko,et al.  A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans. , 1991, Journal of lipid research.

[18]  H. Kempen,et al.  Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. , 1988, Journal of lipid research.

[19]  C. Fielding,et al.  Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. , 1988, Biochemistry.

[20]  A. Lacko,et al.  Isolation, characterization, and assay of lecithin-cholesterol acyltransferase. , 1986, Methods in enzymology.

[21]  C. Cortese,et al.  Are plasma lipoprotein cholesteryl esters utilized for biliary cholesterol and bile acid production in man? , 1985, Life sciences.

[22]  B. Lewis,et al.  Relationships between the metabolism of high‐density and very‐low‐density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity , 1982, European journal of clinical investigation.

[23]  P. Nestel,et al.  Relationships between plasma lipoprotein cholesterol concentrations and the pool size and metabolism of cholesterol in man. , 1976, Atherosclerosis.

[24]  G. Mills,et al.  The lipids and lipoproteins of human peripheral lymph, with observations on the transport of cholesterol from plasma and tissues into lymph. , 1973, Clinical science and molecular medicine.

[25]  F. C. Courtice.  The Chemistry of Lymph , 1972 .